PinkDx, Inc.
Risa Stack, Ph.D., currently serves as a Board Member at PinkDx, Inc. and Dextera Biosciences, contributing to the development of innovative drug modalities. Stack is also a Partner at The Production Board, which focuses on technology businesses in life sciences, food, agriculture, and software. Additionally, Stack is a co-founder and Board member at Menlo Micro, where the aim is to transform electronic switch technology. Previous roles include Board member at Metagenomi, where oversight included the Audit and Transaction Committees, and several executive positions in healthcare innovation, including Entrepreneur in Residence at RA Capital Management, Managing Director at RS Bioventures, and Board roles at Drawbridge Health and Avitas Systems. Stack has a Ph.D. in Immunology from The University of Chicago Pritzker School of Medicine and a BS with Distinction in Genetics and Development from the University of Illinois Urbana-Champaign, in addition to being a Kauffman Fellow.
This person is not in the org chart
This person is not in any teams
PinkDx, Inc.
PinkDx is an early-stage women’s Healthcare company dedicated to building a leading enterprise bringing equitable care to women. Initially, the company is focused on the discovery and development of novel, new approaches to improve the journey millions of women navigate in getting answers to symptoms that are suspicious for cancer. PinkDx tests will improve patient outcomes, provide answers for physicians, and reduce the time and cost of care. The PinkDx co-founders are industry veterans with a passion for building a women’s health enterprise and for the opportunity to have impact for women all over the world. The Company has raised a $40 million Series A from top investors.